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mind the patient of his disease, and people
immediately recognize the patient as ill. In
addition, personal mobility is limited be-
cause of the extracorporeal driving unit.
All of these factors limit quality of life.
The greater power of pulsatile devices
is often considered an advantage compared
with axial-flow pumps. However, experi-
ence shows that a flow of 3 to 5 L/min,
which is easily provided by axial-flow de-
vices, is sufficient support for daily activi-
ties. The continuous flow is well tolerated.
This fact may be, at least in part, explained
by the flow characteristics. Patients on ax-
ial-flow pumps have a less pulsatile flow
pattern because the activity of the native
heart at rest transmits pulse waves through
the pump. This activity is obviously suffi-
cient to reestablish and maintain normal
organ function.
Taking all of these factors into account,
the authors prefer axial-flow devices for
long-term support. For destination therapy,
the authors currently use the Berlin Heart
Incor, which is being evaluated for this
indication in the INDESTINY trial. The
management of anticoagulation and plate-
let inhibition in patients with axial-flow
devices still remains an unsolved problem.
Experience with the DeBakey VAD, which
was the first axial-flow pump on the mar-
ket, showed that, in such pumps, platelet
inhibition in addition to anticoagulation is
even more important than in pulsatile de-
vices. In our own experience with the De-
Bakey VAD, administration of clopidogrel
(75 mg) in addition to aspirin (300 mg) and
dipyridamol (75 mg) as well as intensifica-
tion of oral anticoagulation (INR 3.5 to 4.5)
reduces the frequency of thromboembolic
events.7 In patients with the Berlin Heart
Incor, the regimen was modified. Antico-
agulation is titrated at an INR of 2.0 to 3.0,
and platelet inhibition consists of aspirin
(100 mg) and clopidogrel (75 mg). Anti-
platelet therapy is individually guided by
different platelet function tests.
We do not yet have the optimal pump
for destination therapy. We need pumps
with better flow characteristics and fluid
dynamics that cause less damage to plate-
lets and reduce the risk of thrombus forma-
tion. It will be interesting to see if the
implantable centrifugal devices that will
soon be on the market have an advantage in
this respect. The pumps are required to run
reliably and service-free for many years,
and their design should allow exchange of
worn parts in a minimally invasive inter-
vention. Completely implantable devices
with controller and energy supply inside
the body, which are currently in develop-
ment, will further increase quality of life
and reduce the risk of infection.
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Is off-pump therapy really the right
choice in urgent coronary grafting?
To the Editor:
I read with interest the article by Stamou
and colleagues,1 wherein they compare the
early outcomes in nonelective myocardial
revascularization in patients undergoing
on-pump and off-pump bypass. However,
it is arguable as to whether the conclusions
drawn from this report will have an endear-
ing and widespread influence on this issue.
First, even though recent studies are
increasingly documenting better outcomes
among patients undergoing off-pump pro-
cedures, a number of well-designed trials
in the past and present (including both elec-
tive and urgent cases) have yielded con-
flicting results in this regard. Also, it is
unclear as to why the urgent cases should
be handled on a separate basis because the
inflammatory effects associated with car-
diopulmonary bypass are likely to be the
same in both elective and nonelective sce-
narios, and the greater risks faced by these
patients might solely be a result of their
emergency nature of presentation, not hav-
ing anything to do with cardiopulmonary
bypass use.
Second, the authors state the superiority
of off-pump surgery in urgent cases on the
basis of the former decreasing the rate of
intra-aortic balloon pump placement and
renal failure. As regards intra-aortic bal-
loon pump placement, studies have shown
that off-pump surgery reduces the need for
its use in elective cases. However, even as
this evidence might tilt the balance toward
off-pump surgery in elective cases, the ar-
gument is unlikely to have a significant
influence on decision making in urgent
cases, in which hemodynamic instability is
often an issue and balloon pump placement
is frequently mandated on purely clinical
grounds. Also, although cardiopulmonary
bypass is shown to have a detrimental in-
fluence on renal function in this report,
recent propensity score study with univar-
iate and multivariate analysis shows that
off-pump grafting itself might not have any
influence in reducing the rate of postoper-
ative renal dysfunction in patients at risk
for nephrologic compromise, raising
doubts regarding the validity of using the
kidney-sparing argument in support of off-
pump surgery.2
Finally, before off-pump surgery is
adapted as the primary approach in urgent
coronary revascularization, it must be kept
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in mind that a small but significant percent-
age of patients undergoing off-pump pro-
cedures do require conversion to cardiopul-
monary bypass, and in case of urgent
conversion, disastrous consequences are
recorded at a significant level, marking the
scope for urgent off-pump use in a selected
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Reply to the Editor:
We appreciate the interest of Dr Ashraf in
our article comparing the outcomes of non-
elective on-pump with those of off-pump
myocardial revascularization. Dr Ashraf is
concerned that our results are not con-
firmed by well-randomized trials compar-
ing the 2 techniques. However, we are not
aware of any randomized controlled trials
comparing the outcomes of patients having
nonelective off-pump coronary artery by-
pass grafting (CABG) with those of histor-
ical control subjects. Such an endeavor
might require randomized trials of imprac-
tical size to prove whether statistically sig-
nificant differences really exist between
these 2 techniques of myocardial revascu-
larization in this subset of high-risk pa-
tients. The authors also question whether
urgent or emergency cases should be han-
dled on a separate basis compared with
elective cases. The answer is yes, with the
main reason being that urgent and emer-
gency myocardial revascularization poses a
greater challenge and has consistently been
associated with worse outcomes compared
with first elective CABG.1 Thus a separate
and more focused analysis on this subgroup
of patients is able to determine the factors
that result in a better or worse clinical
outcome.
In regard to the issue of decreased rate
of postoperative intra-aortic balloon place-
ment and renal failure after off-pump
CABG demonstrated in our study, Dr
Ashraf quotes a recent article not showing
any benefit of off-pump compared with on-
pump CABG in regard to the occurrence of
postoperative renal function. The study he
quotes,2 however, is a not well-balanced
study, including only 158 patients in the
off-pump arm and comparing those with
2869 patients having on-pump CABG in
the same period of time. One might wonder
whether the authors of the study were equally
comfortable with both techniques because
they performed only about one tenth the off-
pump cases compared with on-pump cases.
In contrast, our 2-institution study compared
2273 patients undergoing off-pump proce-
dures with 3487 undergoing on-pump proce-
dures and, after a robust statistical methodol-
ogy, was able to document a lower rate of
intra-aortic balloon pump placement and a
decreased rate of postoperative renal failure,
as well as a decreased length of stay after
off-pump compared with on-pump nonelec-
tive CABG. Moreover, multiple previous
studies, including some randomized con-
trolled studies,3,4 have documented a lower
rate of postoperative renal dysfunction after
off-pump compared with on-pump CABG.5
Finally, we tend to agree with Dr Ashraf that
a conversion to cardiopulmonary bypass in
cases of urgent myocardial revascularization
will be associated with worse outcomes, and
thus a careful selection of patients chosen for
off-pump surgery by surgeons comfortable
with both approaches would be necessary to
optimize clinical outcome.
Sotiris C. Stamou, MD, PhD
Department of Thoracic and Cardiovascular
Surgery
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Atrial ablation and esophageal
injury: Comments on an experimental
study
To the Editor:
In the December issue of the Journal, we
read with enormous interest the article en-
titled “Ablation of atrial fibrillation and
esophageal injury: effects of energy source
and ablation technique” by Aupperle and
colleagues.1 The authors performed in vivo
experiments on 39 sheep to evaluate the his-
tologic changes induced in the esophagus by
using atrial fibrillation ablation with different
energy types, such as cryoablation, micro-
wave, laser, and unipolar or bipolar radiofre-
quency, through 2 different approaches, en-
docardial and epicardial. They observed
esophageal alterations in numerous cases
and concluded that the most significant le-
sions (moderate and severe damage) were
principally induced by endocardial unipolar
radiofrequency and cryoablation. We would
like to comment on a number of issues.
The esophageal thermal lesion, which is
similar to those found in myocardial ther-
mal lesions, is mainly based on the quantity
of energy absorbed by the tissue, the type of
energy, and the distance between the ablation
electrode and the esophagus. Aupperle and
colleagues1 have compared different types
of energy applications with standard clini-
cal protocols. However, they do not con-
sider the distance between the electrode
and the esophagus or the individual varia-
tions in myocardial thickness; that is, no
allowance was made for these parameters
in the groups under study. Several clinical
studies have shown a short anatomic dis-
tance between the left atrium and the
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